Staff Scientist, Molecular and Cellular Biology (industry experience required)
Septerna
About this role
Septerna, a biotechnology company based in South San Francisco, focuses on G protein-coupled receptor (GPCR) drug discovery using their Native Complex Platform. They aim to develop innovative medicines for patients with unmet medical needs and are seeking a scientist to support their small molecule drug discovery pipeline.
Skills
About Septerna
septerna.comSepterna is a biotechnology company developing GPCR-targeted medicines using its Native Complex Platform to discover and advance innovative therapeutics.
Recent company news
MarketBeatAvoro Capital Advisors LLC Grows Stock Holdings in Septerna, Inc. $SEPN
2 days ago
MSNNovo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna
4 days ago
Simply Wall StreetSepterna (SEPN) Q4 Loss Despite Revenue Surge Reinforces Bearish Profitability Narrative
5 days ago
The Globe and MailAnalysts Conflicted on These Technology Names: Fortinet (FTNT), Septerna, Inc. (SEPN) and Oracle (ORCL)
4 days ago
Stock TitanSEPN SEC Filings - Septerna, Inc. 10-K, 10-Q, 8-K Forms
1 week ago
About Septerna
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Septerna.
Salary
$140k – $170k
per year
More jobs at Septerna
Similar Jobs
Post-Doc Research Associate
Trinity College
Scientist to Principal Scientist, in-vitro Biology
Structure Therapeutics
Research Technician I- G Protein- Lefkowitz Lab
Howard Hughes Medical Institute
Senior Scientist/Principal Scientist - Lead Generation
Superluminal Medicines, Inc.
Post-Doctoral Fellow Center for Translational Research, Lab of Dr. Penn
Thomas Jefferson University
Principal Scientist to Associate Director, Biology
Structure Therapeutics